Safety and effectiveness of efgartigimod for intravenous infusion in patients with generalized myasthenia gravis: an interim analysis of Japanese post-marketing surveillance
Safety and effectiveness of efgartigimod for intravenous infusion in patients with generalized myasthenia gravis: an interim analysis of Japanese post-marketing surveillance
Daisuke Harada, Koichi Tsuda, Ryu Kanzaki, Hirofumi Teranishi et al.
Citations
3 citations
Journal
Expert Opinion on Biological Therapy
Topics
Myasthenia Gravis and Thymoma
Field-Weighted Citation Impact (FWCI)
4.17
article
Safety and effectiveness of efgartigimod for intravenous infusion in patients with generalized myasthenia gravis: an interim analysis of Japanese post-marketing surveillance
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Safety and effectiveness of efgartigimod for intravenous infusion in patients with generalized myasthenia gravis: an interim analysis of Japanese post-marketing surveillance — Daisuke Harada, Koichi Tsuda, et al. · Expert Opinion on Biological Therapy (2025) | TGRS Research Map | TGRS